Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(−receptor) antibodies
Authors (first, second and last of 8)
Volume 22, issue 1, December 2021
156 articles in this issue
-
-
Characteristics of N400 component elicited in patients who have migraine with aura
Authors (first, second and last of 4)
-
Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States
Authors (first, second and last of 10)
-
Is there a causal relationship between stress and migraine? Current evidence and implications for management
Authors (first, second and last of 5)
-
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study
Authors (first, second and last of 15)
-
The relationship between headache-attributed disability and lost productivity: 2. Empirical evidence from population-based studies in nine disparate countries
Authors (first, second and last of 7)
This is part of 1 collection:
-
Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
Authors (first, second and last of 8)
-
In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study
Authors (first, second and last of 5)
-
Increase in ACC GABA+ levels correlate with decrease in migraine frequency, intensity and disability over time
Authors (first, second and last of 10)
-
Preventive treatment with CGRP monoclonal antibodies restores brain stem habituation deficits and excitability to painful stimuli in migraine: results from a prospective case-control study
Authors (first, second and last of 8)
-
Age- and frequency-dependent changes in dynamic contrast perception in visual snow syndrome
Authors (first, second and last of 6)
-
Altered brain functional network dynamics in classic trigeminal neuralgia: a resting-state functional magnetic resonance imaging study
Authors (first, second and last of 8)
-
Src family kinases activity is required for transmitting purinergic P2X7 receptor signaling in cortical spreading depression and neuroinflammation
Authors (first, second and last of 4)
This is part of 1 collection:
-
Major sex differences in migraine prevalence among occupational categories: a cross-sectional study using UK Biobank
Authors (first, second and last of 4)
-
Which is the best transcranial direct current stimulation protocol for migraine prevention? A systematic review and critical appraisal of randomized controlled trials
Authors (first, second and last of 9)
-
Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies
Authors (first, second and last of 6)
-
Metabolic profile changes in serum of migraine patients detected using 1H-NMR spectroscopy
Authors (first, second and last of 7)
This is part of 1 collection:
-
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Authors (first, second and last of 10)
-
Total health insurance costs in children with a migraine diagnosis compared to a control group
Authors (first, second and last of 7)
-
Tracking tDCS induced grey matter changes in episodic migraine: a randomized controlled trial
Authors (first, second and last of 8)
-
Parenchymal neuroinflammatory signaling and dural neurogenic inflammation in migraine
Authors
This is part of 1 collection:
-
Altered static and dynamic functional network connectivity in post-traumatic headache
Authors (first, second and last of 8)
-
The management and clinical knowledge of headache disorders among general practitioners in Norway: a questionnaire survey
Authors (first, second and last of 7)
-
Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
Authors (first, second and last of 6)
-
Pain sensitivity in men who have never experienced a headache: an observer blinded case control study
Authors (first, second and last of 10)
-
Real-world evidence data on the monoclonal antibody erenumab in migraine prevention: perspectives of treating physicians in Germany
Authors (first, second and last of 5)
-
Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine
Authors (first, second and last of 8)
-
Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
Authors (first, second and last of 10)
-
Regional homogeneity alterations in multi-frequency bands in tension-type headache: a resting-state fMRI study
Authors (first, second and last of 13)
-
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Authors (first, second and last of 7)
-
Differences in gray matter volume in episodic migraine patients with and without prior diagnosis or clinical care: a cross-sectional study
Authors (first, second and last of 5)
-
-
Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
Authors (first, second and last of 6)
-
Risk for ischemic stroke and coronary heart disease associated with migraine and migraine medication among older adults
Authors (first, second and last of 9)
-
Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension
Authors (first, second and last of 4)
-
Angioarchitectural features amongst patients with unruptured brain arteriovenous malformations presenting with headache: findings from a single center retrospective review of 76 patients
Authors (first, second and last of 11)
-
Inflammatory complications of CGRP monoclonal antibodies: a case series
Authors (first, second and last of 13)
-
Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
Authors (first, second and last of 5)
-
Prenatal oestrogen-testosterone balance as a risk factor of migraine in adults
Authors (first, second and last of 6)
-
Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
Authors (first, second and last of 12)
-
Identification of disease- and headache-specific mediators and pathways in migraine using blood transcriptomic and metabolomic analysis
Authors (first, second and last of 16)
-
-
Correction to: CGRP induces migraine-like symptoms in mice during both the active and inactive phases
Authors (first, second and last of 10)
-
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
Authors (first, second and last of 10)
-
Efficacy of galcanezumab in patients with migraine and history of failure to 3–4 preventive medication categories: subgroup analysis from CONQUER study
Authors (first, second and last of 6)
-
Leveraging high-resolution 7-tesla MRI to derive quantitative metrics for the trigeminal nerve and subnuclei of limbic structures in trigeminal neuralgia
Authors (first, second and last of 12)
-
CGRP antibody therapy in patients with drug resistant migraine and chronic daily headache: a real-world experience
Authors (first, second and last of 7)
-
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial
Authors (first, second and last of 10)
-
Osmophobia in primary headache patients: associated symptoms and response to preventive treatments
Authors (first, second and last of 4)
-
Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis
Authors (first, second and last of 12)
